2nd Quarter - Report

SAM ACTION, INC. for SAM ACTION, INC.

Firm
Client
Income
—
Expenses
$30,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

8 issue areas, each in the filer's own words, with who lobbied on it and where.

Small Business SMB

Preventing federally illegal enterprises from gaining a special carve out to access federally subsidized loans or grants.

LobbyistCovered position, as disclosed
FREDERICK BAIRD New —
JENNIFER BAIRD New —
GARTH VAN METER Deputy Chief of Staff, Rep. John Fleming (LA-4)

Contacted: Drug Enforcement Administration (DEA); Natl Institutes of Health (NIH); Small Business Administration (SBA); Justice, Dept of (DOJ); White House Office; SENATE; Office of Natl Drug Control Policy (NDCP); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Alcohol and Drug Abuse ALC

The effects of marijuana on children, the nexus between marijuana and psychosis

LobbyistCovered position, as disclosed
LUKE ALBEE New Chief of Staff, Senator Leahy; Chief of Staff, Mark Warner; Staff, Governor Dukakis
FREDERICK BAIRD —
JENNIFER BAIRD —
GARTH VAN METER US Rep. John Fleming (LA-4), Deputy Chief of Staff

Contacted: White House Office; HOUSE OF REPRESENTATIVES; Office of Natl Drug Control Policy (NDCP); Natl Institutes of Health (NIH); SENATE; Food & Drug Administration (FDA); Justice, Dept of (DOJ); Drug Enforcement Administration (DEA); Small Business Administration (SBA)

Government Issues GOV

federal role in marijuana laws, the legalization of marijuana, criminal justice reform

LobbyistCovered position, as disclosed
LUKE ALBEE Chief of Staff, Senator Leahy; Chief of Staff, Mark Warner; Staff, Governor Dukakis
FREDERICK BAIRD —
JENNIFER BAIRD —
GARTH VAN METER US Rep. John Fleming (LA-4), Deputy Chief of Staff

Contacted: Food & Drug Administration (FDA); Natl Institutes of Health (NIH); Small Business Administration (SBA); HOUSE OF REPRESENTATIVES; Justice, Dept of (DOJ); Office of Natl Drug Control Policy (NDCP); SENATE; Drug Enforcement Administration (DEA); White House Office

Medical/Disease Research/Clinical Labs MED

H.R. 3797, Medical Marijuana Research Act, S. 2032, Cannabidiol and Marihuana Research Expansion Act, to lower the barriers of researching marijuana

LobbyistCovered position, as disclosed
GARTH VAN METER Deputy Chief of Staff, Rep. John Fleming (LA-4)

Contacted: HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Drug Enforcement Administration (DEA); Natl Institutes of Health (NIH); Office of Natl Drug Control Policy (NDCP); Small Business Administration (SBA); SENATE; Justice, Dept of (DOJ); White House Office

Bills named: H.R. 3797 (116th), S. 2032 (116th)

Law Enforcement/Crime/Criminal Justice LAW

H.R. 2093/S. 1028, STATES Act to legalize marijuana, appropriations amendments related to marijuana legalization, criminal justice reform related to marijuana, H.R. 3884, MORE Act.

LobbyistCovered position, as disclosed
LUKE ALBEE Chief of Staff, Senator Leahy; Chief of Staff, Mark Warner; Staff, Governor Dukakis
FREDERICK BAIRD —
JENNIFER BAIRD —
GARTH VAN METER Deputy Chief of Staff, Rep. John Fleming (LA-4)

Contacted: White House Office; Office of Natl Drug Control Policy (NDCP); Natl Institutes of Health (NIH); Justice, Dept of (DOJ); SENATE; Drug Enforcement Administration (DEA); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Small Business Administration (SBA)

Bills named: H.R. 2093 (116th), S. 1028 (116th), H.R. 3884 (116th)

Consumer Issues/Safety/Products CSP

safety issues surrounding marijuana, marketing of high potency marijuana products to children

LobbyistCovered position, as disclosed
LUKE ALBEE Chief of Staff, Senator Leahy; Chief of Staff, Mark Warner; Staff, Governor Dukakis
FREDERICK BAIRD —
JENNIFER BAIRD —
GARTH VAN METER Deputy Chief of Staff, Rep. John Fleming (LA-4)

Contacted: Justice, Dept of (DOJ); SENATE; Office of Natl Drug Control Policy (NDCP); White House Office; Food & Drug Administration (FDA); Natl Institutes of Health (NIH); HOUSE OF REPRESENTATIVES; Small Business Administration (SBA); Drug Enforcement Administration (DEA)

Health Issues HCR

the effects of marijuana on children, pregnant women and developing brains, the nexus between high potency marijuana and mental illness

LobbyistCovered position, as disclosed
LUKE ALBEE Chief of Staff, Senator Leahy; Chief of Staff, Mark Warner; Staff, Governor Dukakis
FREDERICK BAIRD —
JENNIFER BAIRD —
GARTH VAN METER US Rep. John Fleming (LA-4), Deputy Chief of Staff

Contacted: Food & Drug Administration (FDA); Natl Institutes of Health (NIH); SENATE; White House Office; Justice, Dept of (DOJ); Drug Enforcement Administration (DEA); HOUSE OF REPRESENTATIVES; Small Business Administration (SBA); Office of Natl Drug Control Policy (NDCP)

Banking BAN

H.R. 1595/S. 1200, SAFE Banking Act on marijuana banking and investment

LobbyistCovered position, as disclosed
LUKE ALBEE Chief of Staff, Senator Leahy; Chief of Staff, Mark Warner; Staff, Governor Dukakis
FREDERICK BAIRD —
JENNIFER BAIRD —
GARTH VAN METER Deputy Chief of Staff, US Rep. John Fleming (LA-4)

Contacted: SENATE; Small Business Administration (SBA); Drug Enforcement Administration (DEA); White House Office; Office of Natl Drug Control Policy (NDCP); Justice, Dept of (DOJ); Natl Institutes of Health (NIH); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Bills named: H.R. 1595 (116th), S. 1200 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.